Asker Healthcare Group AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	402	360	203	430	467
Depreciation & Amortization	618	548	502	341	185
Other Amortization	60	60	46	54	45
Loss (Gain) From Sale of Assets	-	-	1	-	-
Other Operating Activities	183	300	179	118	-108
Change in Accounts Receivable	16	292	-217	-22	239
Change in Inventory	-68	-144	21	-12	-181
Change in Other Net Operating Assets	-209	-189	317	67	-265
Operating Cash Flow	1,002	1,227	1,052	976	382
Operating Cash Flow Growth	2.66%	16.63%	7.79%	155.50%	-
Capital Expenditures	-501	-348	-151	-123	-124
Sale of Property, Plant & Equipment	-	-	-	1	-
Cash Acquisitions	-1,625	-1,109	-632	-1,738	-719
Investing Cash Flow	-2,126	-1,457	-783	-1,860	-843
Long-Term Debt Issued	-	593	77	902	858
Long-Term Debt Repaid	-	-296	-219	-734	-235
Net Debt Issued (Repaid)	661	297	-142	168	623
Issuance of Common Stock	1,407	-	63	399	1
Other Financing Activities	32	8	-4	5	-5
Financing Cash Flow	2,100	305	-83	572	619
Foreign Exchange Rate Adjustments	-7	24	-5	29	3
Miscellaneous Cash Flow Adjustments	1	-	-1	-	-
Net Cash Flow	970	99	180	-283	161
Free Cash Flow	501	879	901	853	258
Free Cash Flow Growth	-41.27%	-2.44%	5.63%	230.62%	-
Free Cash Flow Margin	3.15%	5.85%	6.70%	7.28%	2.76%
Free Cash Flow Per Share	1.79	3.34	3.44	3.30	1.09
Cash Interest Paid	221	228	192	95	-
Cash Income Tax Paid	280	201	126	100	85
Levered Free Cash Flow	-	478.5	698	400.38	-
Unlevered Free Cash Flow	-	667.25	863	516.63	-
Change in Working Capital	-261	-41	121	33	-207

Source: S&P Global Market Intelligence. Standard template. Financial Sources.